rs553114356
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001182.5(ALDH7A1):c.1046G>C(p.Arg349Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000521 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001182.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH7A1 | NM_001182.5 | c.1046G>C | p.Arg349Thr | missense_variant | Exon 12 of 18 | ENST00000409134.8 | NP_001173.2 | |
ALDH7A1 | NM_001201377.2 | c.962G>C | p.Arg321Thr | missense_variant | Exon 12 of 18 | NP_001188306.1 | ||
ALDH7A1 | NM_001202404.2 | c.1008+3262G>C | intron_variant | Intron 11 of 15 | NP_001189333.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251396Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135860
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461296Hom.: 0 Cov.: 30 AF XY: 0.0000688 AC XY: 50AN XY: 726996
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74336
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Uncertain:4
- -
This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 349 of the ALDH7A1 protein (p.Arg349Thr). This variant is present in population databases (rs553114356, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ALDH7A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 204841). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ALDH7A1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
not provided Uncertain:2
p.Arg349Thr (AGA>ACA): c.1046 G>C in exon 12 of the ALDH7A1 gene (NM_001182.4). The R349T variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position that is not conserved across species. However, the R349T variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In addition, a missense mutation in a nearby residue (Y354C) has been reported in association with pyridoxine-dependent epilepsy. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -
- -
Inborn genetic diseases Uncertain:1
The p.R349T variant (also known as c.1046G>C), located in coding exon 12 of the ALDH7A1 gene, results from a G to C substitution at nucleotide position 1046. The arginine at codon 349 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at